We are live on ! Find out more
PAVM icon

PAVmed
PAVM

97 hedge funds and large institutions have $134M invested in PAVmed in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more capital invested

Capital invested by funds: $80.7M → $134M (+$53.8M)

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

54% more call options, than puts

Call options by funds: $1.83M | Put options by funds: $1.19M

37% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 19

7% more funds holding

Funds holding: 91 → 97 (+6)

0.01% more ownership

Funds ownership: 0.05% → 0.06% (+0.01%)

Holders
97
Holders Change
+6
Holders Change %
+6.59%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
33
Reduced
21
Closed
19
Calls
$1.83M
Puts
$1.19M
Net Calls
+$642K
Net Calls Change
+$718K

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$5.3M
2
EI
EAM Investors
California
+$4.18M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.01M
4
EGI
EAM Global Investors
California
+$1.97M
5
State Street
State Street
Massachusetts
+$1.91M

Top Sellers

Rank Fund Capital Flow
1
MWNA
Marshall Wace North America
New York
-$2.33M
2
PGM
Parian Global Management
New York
-$1.94M
3
Millennium Management
Millennium Management
New York
-$1.71M
4
Marshall Wace
Marshall Wace
United Kingdom
-$806K
5
Creative Planning
Creative Planning
Kansas
-$702K
Name Holding Trade Value Shares
Change 		Change in
Stake
Voloridge Investment Management
26
Voloridge Investment Management
Florida
$549K +$451K +191 New
CCA
27
Cruiser Capital Advisors
Connecticut
$544K – – –
Federated Hermes
28
Federated Hermes
Pennsylvania
$484K +$397K +168 New
Two Sigma Investments
29
Two Sigma Investments
New York
$466K -$654K -277 -63%
Goldman Sachs
30
Goldman Sachs
New York
$456K +$61.4K +26 +20%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$402K +$170K +72 +106%
Carson Wealth (CWM LLC)
32
Carson Wealth (CWM LLC)
Nebraska
$399K – – –
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$398K +$165K +70 +103%
CS
34
Credit Suisse
Switzerland
$393K +$250K +106 +353%
PCA
35
Pallas Capital Advisors
Massachusetts
$362K +$113K +48 +72%
Deutsche Bank
36
Deutsche Bank
Germany
$357K +$87.4K +37 +43%
VF
37
Virtu Financial
New York
$355K +$291K +123 New
Marshall Wace
38
Marshall Wace
United Kingdom
$337K -$806K -341 -74%
BAM
39
Belpointe Asset Management
Nevada
$320K -$78K -33 -23%
TWM
40
Tradition Wealth Management
Minnesota
$320K -$11.8K -5 -4%
WP
41
WealthPLAN Partners
Nebraska
$297K – – –
BSW
42
Buckingham Strategic Wealth
Missouri
$275K -$47.2K -20 -17%
RJA
43
Raymond James & Associates
Florida
$270K +$222K +94 New
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$265K +$18.9K +8 +10%
AllianceBernstein
45
AllianceBernstein
Tennessee
$259K +$213K +90 New
JF
46
Jump Financial
Illinois
$233K +$191K +81 New
OIA
47
OneDigital Investment Advisors
Kansas
$230K +$4.72K +2 +3%
AQR Capital Management
48
AQR Capital Management
Connecticut
$226K – – –
Squarepoint
49
Squarepoint
New York
$224K +$184K +78 New
LCS
50
Levin Capital Strategies
New York
$218K – – –
1
2
3 4 5

PAVM Hedge Fund Activity: Q2 2021 in Review

97 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2021, worth a combined $134M — up 67% from $80.7M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new PAVM positions and 19 closed out — a net gain of 7 holders — while 33 added to existing stakes and 21 trimmed.

The largest buyer was Nuveen, adding an estimated $5.3M. The largest seller was Marshall Wace North America, cutting an estimated $2.33M.

  • 97 institutional investors held PAVmed (PAVM) as of Q2 2021, up from 91 in Q1 2021.
  • Funds reported $134M of PAVmed stock for Q2 2021, up 67% quarter-over-quarter.
  • 26 funds opened new PAVmed positions in Q2 2021 and 19 closed out, a net change of +7 holders.
  • The largest PAVmed buyer in Q2 2021 was Nuveen, an estimated $5.3M added.
  • The largest PAVmed seller in Q2 2021 was Marshall Wace North America, an estimated $2.33M sold.

Based on aggregated 13F filings for Q2 2021.